Skin Diseases  >>  albumin-bound paclitaxel  >>  Phase 3
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
albumin-bound paclitaxel / Generic mfg.
RIBBON 2, NCT00281697: A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer

Checkmark P3 data (RIBBON-2) - ASCO-BC
Sep 2012 - Sep 2012: P3 data (RIBBON-2) - ASCO-BC
Checkmark P3 data (TNBC) RIBBON2
Mar 2012 - Mar 2012: P3 data (TNBC) RIBBON2
Checkmark Data
More
Completed
3
684
US
Bevacizumab, Avastin, Placebo, Standard chemotherapy
Genentech, Inc.
Metastatic Breast Cancer
03/09
09/12
SAPPHIRE, NCT02019277: A Study of Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

Completed
3
50
RoW
Docetaxel, Nab-paclitaxel, Paclitaxel, Pertuzumab, Perjeta, Trastuzumab, Herceptin
Hoffmann-La Roche
Breast Cancer
11/16
11/16
NCT02101021 / 2014-004480-20: Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Terminated
3
25
US
Momelotinib, GS-0387, CYT387, Placebo to match momelotinib, Nab-paclitaxel, Gemcitabine
Sierra Oncology LLC - a GSK company
Metastatic Pancreatic Ductal Adenocarcinoma
04/17
04/17
NCT01204437 / 2008-003995-23: Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast

Checkmark EBCC 2014
Mar 2014 - Mar 2014: EBCC 2014
Completed
2/3
400
Europe
Epirubicin, Cyclophosphamide, Cyclophosphamide, Methotrexate, 5 FU, Capecitabine, Nab-Paclitaxel
German Breast Group
Breast Cancer
01/14
01/14
NCT01881230 / 2013-000113-20: Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

Checkmark From tnAcity trial in triple-negative breast cancer
Dec 2016 - Dec 2016: From tnAcity trial in triple-negative breast cancer
Completed
2/3
191
Canada, US, Europe, RoW
nab-Paclitaxel, Abraxane, Carboplatin, Paraplatin,, Paraplatin AQ, Gemcitabine, Gemzar
Celgene
Breast Tumor, Breast Cancer, Cancer of the Breast, Estrogen Receptor- Negative Breast Cancer, HER2- Negative Breast Cancer, Progesterone Receptor- Negative Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer, Triple-negative Breast Cancer, Triple-negative Metastatic Breast Cancer, Metastatic Breast Cancer
10/16
10/16

Download Options